Jianyang Wang

FDA investigator

Appears on 3 documents from 2022 to 2023, mostly at sites in North Carolina. Most often cites testing and approval or rejection of components, drug product containers, and closures (21 CFR 211.84).

3
Documents on file
2.0
Observations per 483
2022
First seen
2023
Most recent

What they cite most

From 6 observations

Activity by year

2022: 1, 2023: 2

Where

North Carolina 2 · Pennsylvania 1

Often inspects with

Anna Kwilas· Bo Liang· Carl Perez

Is Jianyang Wang coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Wyeth Pharmaceutical Division of Wyeth Holdings LLCNov 10, 2023 · Sanford, North Carolina
483 FDA Form 483 Pfizer, Sanford, NC Nov 2023Nov 10, 2023 · Sanford, North Carolina
483 Krystal Biotech, Inc.Nov 16, 2022 · Pittsburgh, Pennsylvania

About this profile

What does Jianyang Wang inspect?

Jianyang Wang appears on 3 documents on file covering 3 sites, mostly in North Carolina.

What do they cite most often?

21 CFR 211.84 (testing and approval or rejection of components, drug product containers, and closures), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jianyang Wang is dated Nov 10, 2023.

FDA Investigator Jianyang Wang: 483s & Inspections · FDA Intel